Novartis and subsidiaries pay US$346 million in US for corruption
By Sara Lewis
Swiss pharmaceuticalsgiant, Novartis AG, plus a former subsidiary Alcon Pte and its current Greekwing, are together to pay
out US$345.9 million in fines to American regulatorsbecause of corrupt practices.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.